The chemistry behind solid-phase peptide synthesis and the analytical methods that verify what is in the vial.
A peptide is, fundamentally, a chain of amino acids linked by peptide bonds. Making one from scratch means choosing the amino acids, ordering them correctly, and forming each bond without damaging the chain. That sounds simple. In practice, the chemistry is delicate, and modern peptide production is the result of decades of refinement.
The dominant method for synthesizing research peptides today is solid-phase peptide synthesis (SPPS), originally developed by Bruce Merrifield in the early 1960s. The approach earned Merrifield the 1984 Nobel Prize in Chemistry and transformed peptide research from a niche pursuit into a routine laboratory technique.
SPPS anchors the growing peptide chain to a solid resin bead. Each amino acid is added one at a time, in reverse order — from the C-terminus to the N-terminus. The basic cycle for each amino acid:
For a 15-amino-acid peptide like BPC-157, this means roughly 15 coupling cycles. For longer peptides — semaglutide is 31 residues, tirzepatide is 39 — the cycle count grows accordingly, and so do the opportunities for error.
No coupling step is 100% efficient. Real-world coupling yields are typically 99-99.5% per step. That sounds high, but errors compound across many cycles. A 99% per-step yield over 40 cycles produces about 67% theoretical full-length peptide. The rest is shorter "deletion sequences" missing one or more residues.
Other common errors:
The crude product after SPPS is therefore not pure peptide — it is a mixture containing the intended sequence plus various impurities. Purification and analysis are essential.
High-Performance Liquid Chromatography (HPLC) is the workhorse purification and analysis technique in peptide chemistry.
The principle is straightforward. A peptide mixture is dissolved and pumped through a column packed with a stationary phase — typically silica beads coated with a hydrophobic material (C18 is most common). A liquid solvent gradient pushes the mixture through the column. Different peptide species interact with the stationary phase differently based on their hydrophobicity, so they exit the column at different times.
The output is a chromatogram — a graph of detector signal versus time. Each peak represents a distinct molecular species. A pure peptide shows one dominant peak. A mixture shows multiple peaks.
For preparative HPLC, fractions corresponding to the desired peak are collected, concentrated, and lyophilized. The resulting peptide is then re-analyzed by HPLC to confirm purity.
Research-grade peptides typically demonstrate purity of 98% or higher on HPLC analysis. A 98% pure peptide means that 98% of the mass in the sample corresponds to the intended sequence, with the remaining 2% being a mixture of deletion sequences, racemized residues, oxidized byproducts, and other impurities.
HPLC tells you a sample is mostly one thing. Mass spectrometry (MS) tells you what that one thing is.
The principle: a peptide is ionized — typically by electrospray ionization (ESI) or matrix-assisted laser desorption/ionization (MALDI) — and accelerated through an electric field. The mass-to-charge ratio of the ions is measured, and from that the molecular weight is calculated.
For peptide verification, the measured molecular weight is compared to the theoretical molecular weight calculated from the amino acid sequence. A match within typical tolerance (0.5-1.0 Da depending on instrument resolution) confirms the intended sequence was produced.
More advanced MS techniques — particularly tandem mass spectrometry (MS/MS) — can fragment the peptide and read the amino acid sequence directly, providing definitive confirmation of identity.
When evaluating a peptide for research use, a credible Certificate of Analysis (COA) should include:
Third-party analysis — performed by an independent laboratory rather than the manufacturer's in-house lab — represents the gold standard. The principle is the same as financial auditing: an independent party with no incentive to overstate quality.
A few real-world issues that even good-looking COAs can mask:
Net vs. gross peptide content. A vial labeled "10 mg" might contain 10 mg of total mass, but only 7-8 mg of actual peptide — the remainder being TFA salt and water. Net peptide content is the relevant number for dosing calculations.
Outdated COAs. A COA from synthesis lot A says nothing about what is in your vial from lot B. Match lot numbers.
Selective reporting. Some manufacturers report only HPLC purity without mass spec confirmation. This tells you the sample is one main thing, but not that the one main thing is what was advertised.
Endotoxin contamination. HPLC and MS do not detect bacterial endotoxins. For research applications where endotoxin matters, separate testing (LAL assay) is required.
Not all SPPS is equivalent. The peptide market broadly includes:
The difference is not whether the chemistry was performed correctly, but the degree of purification, quality control, and regulatory oversight applied to the output.
NoteThis article is intended for informational and educational purposes only. It does not constitute medical advice.
Still have questions?
ASK AXIOM ABOUT THIS TOPIC →